ATLANTA, GA – – (Globe Newswire – December 18, 2024) – – A shareholder class action lawsuit has been filed against Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT). The lawsuit alleges that Defendants made materially false or misleading statements and/or concealed material adverse facts concerning the true state of Applied Therapeutics’ Phase III INSPIRE trial; notably, electronic data capture issues and a dosing error in the dose-escalation phase of the study.

If you bought shares of Applied Therapeutics between January 3, 2024 and December 2, 2024, and you suffered a significant loss on that investment, you are encouraged to discuss your legal rights by contacting Corey D. Holzer, Esq. at cholzer@holzerlaw.com, by toll-free telephone at (888) 508-6832 or you may visit the firm’s website at www.holzerlaw.com/case/applied-therapeutics/ to learn more.

The deadline to ask the court to be appointed lead plaintiff in the case is February 18, 2025.